Please login to the form below

Not currently logged in
Email:
Password:

Hal Barron

This page shows the latest Hal Barron news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s Corsico to be new GSK drug dev leader

Boehringer’s Corsico to be new GSK drug dev leader

Chris Corsico (Image: Transcelerate). Corsico takes up his new post on 1 January 2019 and will report to Hal Barron, GSK’s chief scientific officer and R&D supremo, who Walmsley ... Corisco will be based at GSK’s UK research base in Stevenage, and

Latest news

More from news
Approximately 1 fully matching, plus 41 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Kevin Sin joins GSK Kevin Sin joins GSK

    years. Dr Hal Barron, chief scientific officer and president of research and development, GSK, said: “I am extremely excited to have Kevin join GSK. ... Sin will report to Hal Barron and will be based at the group’s San Francisco office.

  • Levinson resigns from Roche board Levinson resigns from Roche board

    He has served as CEO at Calico, Google's health research business, since its formation in September 2013 and has since been joined by former Genentech/Roche colleagues Hal Barron, David

  • Roche CMO joins Google health venture Calico Roche CMO joins Google health venture Calico

    Roche CMO joins Google health venture Calico. Hal Barron among four new appointments. ... Dr Hal Barron has left his role as chief medical officer of Swiss pharma company Roche to join Google's recently-launched health research arm Calico as its

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics